NEW DELHI – India is considering lowering tariffs on agricultural products, pharmaceuticals, and other key imports from the United States as part of a broader trade negotiation between the two ...

India supplies over 45% of the generics and 15% of biosimilars used in the U.S., with major companies like Dr. Reddy’s, Aurobindo Pharma, Zydus Lifesciences, Sun Pharma, and Gland Pharma earning ...

New Jersey-based Glenmark Pharmaceuticals Inc is withdrawing affected lots of medications including Propafenone Hydrochloride extended-release capsules and Solifenacin Succinate Tablets. The company ...

A Russian missile struck a warehouse belonging to Kusum Healthcare, an Indian pharmaceutical company, in Ukraine, prompting condemnation from the Ukrainian embassy, which alleged a deliberate ...

NEW DELHI: Drug makers Glenmark, Sun Pharma and Zydus are recalling products in the US for manufacturing issues, the US Food and Drug Administration (USFDA) said in its latest Enforcement Report.

The stock's rally comes on the back of a US Court of Appeals ruling that vacated a previous injunction imposed by the District Court of New Jersey. The injunction had temporarily barred Sun Pharma ...

Sun Pharma shares gained after a U.S. court lifted an injunction, clearing the way for the launch of LEQSELVI, its drug for autoimmune-related hair loss. The legal battle with Incyte continues, but ...

The US Court of Appeals has vacated the preliminary injunction against Sun Pharma’s launch of Leqselvi which was granted by the US District Court of New Jersey in Nov-24. While the decision of ...

Drugmaker Sun Pharma on Thursday said the U.S. Court of Appeals for the Federal Circuit has vacated a preliminary injunction effective immediately that thus far restricted the company from ...

Mumbai, April 10 Sun Pharmaceutical Industries on Thursday said that it has received a major relief from a US court, which allowed it to launch its new drug Leqselvi (Deuruxolitinib) in the American ...

Sun Pharmaceutical Industries Ltd can now launch LEQSELVI, a drug for an autoimmune disorder causing hair loss, after a US court vacated a preliminary injunction. The company was embroiled in a patent ...

Sun Pharma wins US court case, lifting restrictions on launching LEQSELVI, a drug for autoimmune disorder causing hair loss. The company will now launch the drug in the US. New Delhi, Apr 10 (PTI) Sun ...